Evidence map›Paper›PMID 40095516›Full record

ReviewJournal of clinical medicine2025

Neutrophil Gelatinase-Associated Lipocalin: Biological Aspects and Potential Diagnostic Use in Acute Kidney Injury.

Grazia Maria Virzì, Niccolò Morisi, Catarina Oliveira Paulo, Anna Clementi, Claudio Ronco, Monica Zanella

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Management of earthquake-related acute renal injury.World journal of nephrology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Grazia Maria VirzìDepartment of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Rodolfi Street 37, 36100 Vicenza, Italy.ORCID 0000-0001-7934-9800
Niccolò MorisiSurgical, Medical, Dental and Morphological Sciences Department (CHIMOMO), University of Modena and Reggio Emilia, 41126 Modena, Italy.
Catarina Oliveira PauloIntensive Care Department, Hospital Garcia de Orta, 2805-267 Almada, Portugal.ORCID 0000-0002-6042-963X
Anna ClementiDepartment of Nephrology and Dialysis, Santa Marta and Santa Venera Hospital, 95024 Acireale, Italy.
Claudio RoncoIRRIV-International Renal Resarch Institute Vicenza, San Bortolo Hospital, Rodolfi Street 37, 36100 Vicenza, Italy.ORCID 0000-0002-6697-4065
Monica ZanellaDepartment of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Rodolfi Street 37, 36100 Vicenza, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is a syndrome characterized by a rise in creatinine or a decrease in urinary flow, according to the Kidney Disease Improving Global Outcomes (KDIGO) definition. It is diagnosed in 15% of inpatients and 50% of patients in the intensive care unit (ICU), and it is related to increased mortality. As part of a global effort aimed at the elimination of preventable deaths from AKI, there is a growing interest in identifying biomarkers that can be point-of-care and that are not influenced by the variability in patient characteristics in a relevant way. Neutrophil gelatinase-associated lipocalin (NGAL), particularly in its 25 kDa form, which is exclusively released by renal tubules, has emerged as a promising biomarker with potential use in the diagnosis of AKI in the critically ill, including its use in guiding the initiation and/or weaning of renal replacement therapy (RRT). The objective of this review is to summarize the current understanding of NGAL in acute settings, emphasizing biological and genomic insights.

Indexed as

AKIbiomarkerdiagnosis of AKIlipocalinNGALRRT

Identifiers

PMID40095516
PMCPMC11900132

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.